Clinical Trials Browser

Phase 1/2 × Sarcoma × Immunoenzyme Techniques × Clear all

NCT00233948 2015-04-01

Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma

Phase 1/2 Terminated

29 enrolled 7 charts

Liposarcoma, Sarcoma